Document Detail


Confirmation of the efficacy of ERr 731 in perimenopausal women with menopausal symptoms.
MedLine Citation:
PMID:  19161045     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: In a previous study, the special extract ERr 731 of Rheum rhaponticum significantly reduced vasomotor and other menopausal symptoms associated with perimenopause. This trial was conducted to confirm the efficacy of ERr 731. DESIGN: A multicenter, randomized, placebo-controlled, clinical trial with 112 perimenopausal women with menopausal symptoms receiving either 1 enteric-coated tablet of ERr 731 (n = 56) or placebo (n = 56) daily for 12 weeks. Primary outcome criterion for efficacy of ERr 731 compared to placebo was the change of the Menopause Rating Scale (MRS) total score from day 0 to day 84. Other efficacy assessments analyzed included the number and severity of hot flushes, individual symptoms of the MRS, treatment outcome, and various safety parameters. RESULTS: By 12 weeks, ERr 731 caused a highly significant reduction of the MRS total score from 27.0 +/- 4.7 points to 12.4 +/- 5.3 points when compared to the placebo-induced decrease from 27.0 +/- 5.3 points to 24.0 +/- 6.2 points (P < .0001). A significant reduction in each individual MRS item score, in hot flushes and the hot flush weekly weighted score, together with a marked improvement in treatment outcome were also observed (P < .0001). These results confirm the efficacy of ERr 731 in alleviating menopausal symptoms in perimenopausal women. Fourteen adverse events were reported in total: 11 by 5 women receiving ERr 731 and 3 by 3 women receiving placebo. ERr 731 was well tolerated by the majority of the women. CONCLUSION: ERr 731 was confirmed to be effective for the treatment of menopausal symptoms in perimenopause.
Authors:
Marietta Kaszkin-Bettag; Boris M Ventskovskiy; Sergey Solskyy; Sabine Beck; Ilona Hasper; Andrei Kravchenko; Reinhard Rettenberger; Andy Richardson; Peter W Heger
Related Documents :
1910795 - Does 360 ml of apple juice ingested before elective surgery worsen gastric volume and a...
6824285 - Comparison of subjective and radiological findings during the course of acute maxillary...
8836705 - Absence of tolerance in duodenal ulcer patients treated for 28 days with a bedtime dose...
7359735 - Cimetidine postmarket outpatient surveillance program. interim report on phase i.
6345045 - Dihydroergotamine in postoperative ileus.
1831185 - Down syndrome and sleep apnea--a therapeutic challenge.
Publication Detail:
Type:  Journal Article; Meta-Analysis; Randomized Controlled Trial    
Journal Detail:
Title:  Alternative therapies in health and medicine     Volume:  15     ISSN:  1078-6791     ISO Abbreviation:  Altern Ther Health Med     Publication Date:    2009 Jan-Feb
Date Detail:
Created Date:  2009-01-23     Completed Date:  2009-03-10     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9502013     Medline TA:  Altern Ther Health Med     Country:  United States    
Other Details:
Languages:  eng     Pagination:  24-34     Citation Subset:  IM    
Affiliation:
University of Frankfurt Medical School, Germany. mkbrhubarb@yahoo.de
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Anxiety Disorders / drug therapy
Climacteric / physiology*
Double-Blind Method
Female
Hot Flashes / drug therapy*
Humans
Middle Aged
Perimenopause*
Phytotherapy / methods*
Plant Extracts / administration & dosage*
Plant Preparations / administration & dosage
Plant Roots
Quality of Life
Rheum*
Tablets, Enteric-Coated
Treatment Outcome
Women's Health
Chemical
Reg. No./Substance:
0/ERr 731; 0/Plant Extracts; 0/Plant Preparations; 0/Tablets, Enteric-Coated

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  How to manage the unmanageable.
Next Document:  Clinical observations and seven-and-one-half-year follow-up of patients using an integrative holisti...